ThePolitibase
H.RES. 1285In Committee

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Sponsor
Rep. DeGette, Diana [D-CO-1]
D · CO-1
Key facts
Introduced: May 14, 2026
Chamber: House
Cosponsors: 12
Congress: 119th
Latest action · May 14, 2026
Referred to the House Committee on Energy and Commerce.

Timeline

  1. May 14, 2026
    Referred to the House Committee on Energy and Commerce.
  2. May 14, 2026
    Submitted in House

Cosponsors

View official record on Congress.gov →
Make your voice heard

Contact your representatives about this bill in under 2 minutes.

📬 Contact Your Reps →